G361-0422 Screening compound: N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(4-methoxyphenyl)-4-oxo-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl]acetamide

G361-0422 Screening compound: N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(4-methoxyphenyl)-4-oxo-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl]acetamide
G361-0422 Screening compound: N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(4-methoxyphenyl)-4-oxo-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl]acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G361-0422
N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(4-methoxyphenyl)-4-oxo-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl]acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G361-0422

Molecular Formula

C29H34N6O3 (C29 H34 N6 O3)

Compound Name

N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(4-methoxyphenyl)-4-oxo-4H,5H-pyrazolo[1,5-d][1,2,4]triazin-5-yl]acetamide

IUPAC name

N-[3-(4-benzylpiperidin-1-yl)propyl]-2-[2-(4-methoxyphenyl)-4-oxo-4H5H-pyrazolo[15-d][124]triazin-5-yl]acetamide

SMILES

COc(cc1)ccc1-c1nn(C=NN(CC(NCCCN2CCC(Cc3ccccc3)CC2)=O)C2=O)c2c1

InChI

InChI=1S/C29H34N6O3/c1-38-25-10-8-24(9-11-25)26-19-27-29(37)34(31-21-35(27)32-26)20-28(36)30-14-5-15-33-16-12-23(13-17-33)18-22-6-3-2-4-7-22/h2-4,6-11,19,21,23H,5,12-18,20H2,1H3,(H,30,36)

InChI Key

LDOKEGXRPBYRMH-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD15003147

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

514.63

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

3.247

Distribution Coefficient, logD

1.155

Water Solubility, LogSw

-3.48

Polar Surface Area

77.713

Acid Dissociation Constant (pKa)

16.02

Base Dissociation Constant (pKb)

9.49

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

37.90

G361-0422 in Drug Discovery

Included in Screening Libraries

CNS targets activity set (6557 compounds)

Human GPCR Annotated Library (5539 compounds)

Human Receptors Annotated Library (5376 compounds)

MCL1 Targeted Library (12200 compounds)

Regenerative Medicine Focused Library (23016 compounds)

Voltage-Gated Ion Channel-Targeted Library (4740 compounds)

Aurora A-B Kinases Targeted Library (9426 compounds)

ChemoGenomic Annotated Library for Phenotypic Screening (89798 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Nervous system
  • Cancer
  • Digestive system
  • Male
  • Female
  • Hemic and lymphatic
Targets:
  • Ion Channels
  • Kinases

References: we are preparing a list of scientific research reports with G361-0422 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G361-0422?
Check Price and Availability of G361-0422, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G361-0422 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G361-0422
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G361-0422
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G361-0422 available by request